GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Daesung Microbiological Labs Co Ltd (XKRX:036480) » Definitions » EV-to-EBITDA

Daesung Microbiological Labs Co (XKRX:036480) EV-to-EBITDA : 25.29 (As of Jun. 11, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Daesung Microbiological Labs Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Daesung Microbiological Labs Co's enterprise value is ₩53,739 Mil. Daesung Microbiological Labs Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₩2,125 Mil. Therefore, Daesung Microbiological Labs Co's EV-to-EBITDA for today is 25.29.

The historical rank and industry rank for Daesung Microbiological Labs Co's EV-to-EBITDA or its related term are showing as below:

XKRX:036480' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.01   Med: 12.11   Max: 408.21
Current: 25.29

During the past 13 years, the highest EV-to-EBITDA of Daesung Microbiological Labs Co was 408.21. The lowest was 4.01. And the median was 12.11.

XKRX:036480's EV-to-EBITDA is ranked worse than
76.6% of 453 companies
in the Biotechnology industry
Industry Median: 9.01 vs XKRX:036480: 25.29

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-11), Daesung Microbiological Labs Co's stock price is ₩10710.00. Daesung Microbiological Labs Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-302.000. Therefore, Daesung Microbiological Labs Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Daesung Microbiological Labs Co EV-to-EBITDA Historical Data

The historical data trend for Daesung Microbiological Labs Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daesung Microbiological Labs Co EV-to-EBITDA Chart

Daesung Microbiological Labs Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.18 21.05 18.30 8.82 20.16

Daesung Microbiological Labs Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.85 17.22 22.29 20.16 24.97

Competitive Comparison of Daesung Microbiological Labs Co's EV-to-EBITDA

For the Biotechnology subindustry, Daesung Microbiological Labs Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daesung Microbiological Labs Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Daesung Microbiological Labs Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Daesung Microbiological Labs Co's EV-to-EBITDA falls into.



Daesung Microbiological Labs Co EV-to-EBITDA Calculation

Daesung Microbiological Labs Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=53739.376/2125.121
=25.29

Daesung Microbiological Labs Co's current Enterprise Value is ₩53,739 Mil.
Daesung Microbiological Labs Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩2,125 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daesung Microbiological Labs Co  (XKRX:036480) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Daesung Microbiological Labs Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=10710.00/-302.000
=At Loss

Daesung Microbiological Labs Co's share price for today is ₩10710.00.
Daesung Microbiological Labs Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-302.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Daesung Microbiological Labs Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Daesung Microbiological Labs Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Daesung Microbiological Labs Co (XKRX:036480) Business Description

Traded in Other Exchanges
N/A
Address
293 Sam-dong, Uiwang, Kyunggi-Do, KOR, 437-040
Daesung Microbiological Labs Co Ltd is engaged in manufacturing and selling vaccines for swine, poultry, canine, cattle, and fish in South Korea. The company offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals.

Daesung Microbiological Labs Co (XKRX:036480) Headlines

No Headlines